---
name: Pull Request Template
about: Template for pull requests
---

## Description

Briefly describe the changes in this pull request.

## Type of Change

- [ ] Bug fix (non-breaking change which fixes an issue)
- [ ] New feature (non-breaking change which adds functionality)
- [ ] Breaking change (fix or feature that would cause existing functionality to not work as expected)
- [ ] Documentation update
- [ ] Refactoring (no functional changes)
- [ ] Performance improvement
- [ ] Other (please describe)

## Related Spec

This PR should be associated with a spec following the GitHub Spec Kit workflow.

- **Spec**: [Link to spec or spec ID]
- **Feature Branch**: [e.g., fantasim-world--feature-name]
- **Worktree**: [Yes/No]

### Spec Kit Phase

- [ ] Specify
- [ ] Plan
- [ ] Tasks
- [ ] Implement
- [ ] Review

## Related RFCs/ADRs

Reference any related RFCs or ADRs:

- RFC: [e.g., RFC-V2-0001]
- ADR: [e.g., ADR-0003]

## Motivation and Context

Why is this change necessary? What problem does it solve? Provide context for reviewers.

## Changes Made

Describe the key changes made in this PR:

-
-
-

## Testing

Describe how you tested these changes:

- [ ] Unit tests added/updated
- [ ] Integration tests added/updated
- [ ] Manual testing performed
- [ ] All tests pass

### Test Coverage

If applicable, provide details on test coverage:

- New tests:
- Modified tests:
- Coverage percentage:

## Breaking Changes

If this PR introduces breaking changes, please describe them:

-
-

## Documentation

- [ ] Code is self-documenting
- [ ] XML documentation comments added/updated
- [ ] README updated (if applicable)
- [ ] CHANGELOG.md updated (if applicable)

## Checklist

- [ ] My code follows the project's code style
- [ ] I have performed a self-review of my code
- [ ] I have commented my code where necessary
- [ ] I have updated the documentation accordingly
- [ ] My changes generate no new warnings
- [ ] I have tested my changes locally
- [ ] I have read and followed the [CONTRIBUTING.md](CONTRIBUTING.md) guidelines
- [ ] I have read and followed the [AGENTS.md](AGENTS.md) agent-specific guidance (if applicable)

## Additional Notes

Any additional context, screenshots, or considerations for reviewers:

## Reviewers

Tag reviewers who should review this PR:

@reviewer1 @reviewer2
